News Focus
News Focus
icon url

CrashOverride

01/15/25 10:56 AM

#743792 RE: theorysuit #743789

Northwest Biotherapeutics isn't "pumping" their share price. They've said very little beyond milestone PRs and required material disclosures in SEC filings which is standard practice for companies seeking regulatory approval.